A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED).

"Guarantor of the article: Walter Reinisch, MD, PhD.: Specific author contributions: Michael Staun, Rakesh K. Tandon, Andrew Thillainayagam, and Lars L. Thomsen were involved in the study design, collection, analysis, and interpretation of data, in the writing of the manuscript, and in the decision to submit the manuscript for publication. Walter Reinisch, Istvan Altorjay, Cornelia Gratzer, and Sandeep Nijhawan were involved in the collection, analysis, and interpretation of data, in the writing of the manuscript, and in the decision to submit the manuscript for publication. All authors read and approved the final manuscript.: Financial support: The study was funded by Pharmacosmos A/S. Pharmacosmos A/S was responsible for setup of the study, collection, analyses, and interpretation of the data, and in the writing of the report.: Potential competing interest: Lars L. Thomsen is employed by Pharmacosmos A/S, and the investigators/institutions received a fee per patients."

"Financial support: The study was funded by Pharmacosmos A/S. Pharmacosmos A/S was responsible for setup of the study, collection, analyses, and interpretation of the data, and in the writing of the report."